415 related articles for article (PubMed ID: 30371563)
1. Predictive and Prognostic Implication of Bowel Resections During Primary Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer.
Bartl T; Schwameis R; Stift A; Bachleitner-Hofmann T; Reinthaller A; Grimm C; Polterauer S
Int J Gynecol Cancer; 2018 Nov; 28(9):1664-1671. PubMed ID: 30371563
[TBL] [Abstract][Full Text] [Related]
2. The impact of type and number of bowel resections on anastomotic leakage risk in advanced ovarian cancer surgery.
Grimm C; Harter P; Alesina PF; Prader S; Schneider S; Ataseven B; Meier B; Brunkhorst V; Hinrichs J; Kurzeder C; Heitz F; Kahl A; Traut A; Groeben HT; Walz M; du Bois A
Gynecol Oncol; 2017 Sep; 146(3):498-503. PubMed ID: 28610745
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.
Gockley AA; Fiascone S; Hicks Courant K; Pepin K; Del Carmen M; Clark RM; Goldberg J; Horowitz N; Berkowitz R; Worley M
Int J Gynecol Cancer; 2019 Mar; 29(3):585-592. PubMed ID: 30833444
[TBL] [Abstract][Full Text] [Related]
4. Oncologic outcomes after splenectomy during initial cytoreductive surgery in advanced epithelial ovarian cancer: a nationwide population-based cohort study.
Said SA; van der Aa MA; Veldmate G; de Hullu JA; van Altena AM
Acta Obstet Gynecol Scand; 2022 Jan; 101(1):56-67. PubMed ID: 34719790
[TBL] [Abstract][Full Text] [Related]
5. Low anterior resection syndrome (LARS) in patients with epithelial ovarian cancer after primary debulking surgery.
Kranawetter M; Ataseven B; Grimm C; Schneider S; Riss S; Alesina P; Prader S; Walz MK; Harpain F; Stift A; Heitz F; Reinthaller A; Polterauer S; Harter P; du Bois A
Gynecol Oncol; 2019 Sep; 154(3):577-582. PubMed ID: 31235241
[TBL] [Abstract][Full Text] [Related]
6. En-bloc pelvic resection with concomitant rectosigmoid colectomy and immediate anastomosis as part of primary cytoreductive surgery for patients with advanced ovarian cancer.
Yildirim Y; Ertas IE; Nayki U; Ulug P; Nayki C; Yilmaz I; Gultekin E; Dogan A; Aykas A; Ulug S; Ozdemir A; Solmaz U
Eur J Gynaecol Oncol; 2014; 35(4):400-7. PubMed ID: 25118481
[TBL] [Abstract][Full Text] [Related]
7. Perioperative outcomes of extensive bowel resection during cytoreductive surgery in patients with advanced ovarian cancer.
Son JH; Kong TW; Paek J; Chang SJ; Ryu HS
J Surg Oncol; 2019 Jun; 119(7):1011-1015. PubMed ID: 30737795
[TBL] [Abstract][Full Text] [Related]
8. Rectosigmoidectomy and Douglas Peritonectomy in the Management of Serosal Implants in Advanced-Stage Ovarian Cancer Surgery: Survival and Surgical Outcomes.
Erkilinç S; Karataşli V; Demir B; Çakir İ; Can B; Karadeniz T; Gökçü M; Sanci M
Int J Gynecol Cancer; 2018 Nov; 28(9):1699-1705. PubMed ID: 30371561
[TBL] [Abstract][Full Text] [Related]
9. Unanticipated 30-day readmission following rectosigmoid resection at the time of cytoreductive surgery in patients with advanced stage ovarian cancer.
Sanders BE; Saharti S; Laus K; Bristow RE; Eskander RN
J Obstet Gynaecol; 2021 Aug; 41(6):956-961. PubMed ID: 33228421
[TBL] [Abstract][Full Text] [Related]
10. Specific Regions, Rather than the Entire Peritoneal Carcinosis Index, are Predictive of Complete Resection and Survival in Advanced Epithelial Ovarian Cancer.
Rosendahl M; Harter P; Bjørn SF; Høgdall C
Int J Gynecol Cancer; 2018 Feb; 28(2):316-322. PubMed ID: 29324538
[TBL] [Abstract][Full Text] [Related]
11. Total rectosigmoidectomy versus partial rectal resection in primary debulking surgery for advanced ovarian cancer.
Plotti F; Montera R; Aloisi A; Scaletta G; Capriglione S; Luvero D; De Cicco Nardone C; Basile S; Benedetti Panici P; Angioli R
Eur J Surg Oncol; 2016 Mar; 42(3):383-90. PubMed ID: 26725211
[TBL] [Abstract][Full Text] [Related]
12. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.
Mourton SM; Temple LK; Abu-Rustum NR; Gemignani ML; Sonoda Y; Bochner BH; Barakat RR; Chi DS
Gynecol Oncol; 2005 Dec; 99(3):608-14. PubMed ID: 16153697
[TBL] [Abstract][Full Text] [Related]
13. National trends in bowel and upper abdominal procedures in ovarian cancer surgery.
Dottino JA; He W; Sun CC; Zhao H; Fu S; Rauh-Hain JA; Suidan RS; Lu KH; Giordano SH; Meyer LA
Int J Gynecol Cancer; 2020 Aug; 30(8):1195-1202. PubMed ID: 32616627
[TBL] [Abstract][Full Text] [Related]
14. Comparison of posterior rectal dissection techniques during rectosigmoid colon resection as part of cytoreductive surgery in patients with epithelial ovarian cancer: Close rectal dissection versus total mesorectal excision.
Son JH; Kim J; Shim J; Kong TW; Paek J; Chang SJ; Ryu HS
Gynecol Oncol; 2019 May; 153(2):362-367. PubMed ID: 30846223
[TBL] [Abstract][Full Text] [Related]
15. Anastomotic leak following interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian Cancer.
Gruner M; Chambers LM; Yao M; Chichura A; Morton M; Costales AB; Horowitz M; Rose PG; Debernardo R; Michener CM
Gynecol Oncol; 2021 Sep; 162(3):645-651. PubMed ID: 34247768
[TBL] [Abstract][Full Text] [Related]
16. Prevention of Anastomotic Leakage in Ovarian Cancer Debulking Surgery and Its Impact on Overall Survival.
Koscielny A; Ko A; Egger EK; Kuhn W; Kalff JC; Keyver-Paik MD
Anticancer Res; 2019 Sep; 39(9):5209-5218. PubMed ID: 31519635
[TBL] [Abstract][Full Text] [Related]
17. Impact of Neoadjuvant Chemotherapy on the Rate of Bowel Resection in Advanced Epithelial Ovarian Cancer.
Philip CA; Pelissier A; Bonneau C; Hequet D; Rouzier R; Pouget N
Anticancer Res; 2016 Sep; 36(9):4865-71. PubMed ID: 27630342
[TBL] [Abstract][Full Text] [Related]
18. When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer.
Brown J; Drury L; Crane EK; Anderson WE; Tait DL; Higgins RV; Naumann RW
J Minim Invasive Gynecol; 2019; 26(5):902-909. PubMed ID: 30240899
[TBL] [Abstract][Full Text] [Related]
19. Morbidity of rectosigmoid resection in cytoreductive surgery for ovarian cancer. Risk factor analysis.
Fournier M; Huchon C; Ngo C; Bensaid C; Bats AS; Combe P; le FrèreBelda MA; Fournier L; Berger A; Lecuru F
Eur J Surg Oncol; 2018 Jun; 44(6):750-753. PubMed ID: 29580734
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of celiac lymph node involvement in patients after frontline treatment for advanced ovarian cancer.
Angeles MA; Ferron G; Cabarrou B; Balague G; Martínez-Gómez C; Gladieff L; Pomel C; Martinez A
Eur J Surg Oncol; 2019 Aug; 45(8):1410-1416. PubMed ID: 30857876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
